Investigation of ototoxic effects of Taxol on a mice model

International Journal of Pediatric Otorhinolaryngology

Volumn 70, Issue 5, 2006, Pages 779-784

  Atas, Ahmet ^a   Agca, Orhan ^a   Sarac, Sarp ^a   Poyraz, Aylar ^b   Akyol, M Umut ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b GAZI UNIVERSITY   (Turkey)

Author keywords

Animal experiment; Ototoxicity; Paclitaxel; Sensorineural hearing loss; Taxol

Indexed keywords

EOSIN; HEMATOXYLIN; PACLITAXEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL VACUOLE; COCHLEA; CONNECTIVE TISSUE; CONTROLLED STUDY; EPITHELIUM CELL; EVOKED BRAIN STEM AUDITORY RESPONSE; FIBROBLAST; HEARING; HEARING LOSS; HISTOPATHOLOGY; INNER EAR; MOUSE; NONHUMAN; OTOTOXICITY; PERIODIC ACID SCHIFF STAIN; PRIORITY JOURNAL; SOUND PRESSURE; STRIA VASCULARIS; TEMPORAL BONE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; AUDITORY THRESHOLD; COCHLEA; EPITHELIAL CELLS; FIBROBLASTS; HEARING LOSS, SENSORINEURAL; INJECTIONS, INTRAPERITONEAL; MICE; MODELS, ANIMAL; PACLITAXEL; RANDOM ALLOCATION; VACUOLES;

EID: 33645295770     PISSN: 01655876     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijporl.2005.11.011     Document Type: Article

References (22)

1. P.B. Schiff, J. Fant, and S.B. Horowitz Promotion of microtubule assembly in vitro by taxol Nature 277 1979 665 667
2. Advanced Ovarian Cancer Trialists Group Chemotherapy in advanced ovarian cancer: an overview of randomised clinical trials BMJ 303 1991 884 893
3. H. Sakai, S. Yoneda, T. Tamura, Y. Nishiwaki, A. Yokoyama, K. Watanabe, and N. Saijo A phase II study of taxol plus cisplatin for advanced non-small-cell lung cancer in Japanese patients Cancer Chemother. Pharmacol. 48 2001 499 503
4. E.A. Perez, C.L. Vogel, D.H. Irwin, J.J. Kirshner, and R. Patel Multicenter phase II trial of weekly taxol in women with metastatic breast cancer J. Clin. Oncol. 19 2001 4216 4223
5. F.R. Dunphy, T.L. Dunleavy, B.R. Harrison, K.M. Trinkaus, H.J. Kim, B.C. Stack Jr., B. Needles, and J.H. Boyd Induction taxol and carboplatin for patients with head and neck carcinoma: analysis of 62 patients treated between 1994 and 1999 Cancer 91 2001 940 948
6. V. Chaudhry, E.K. Rowinsky, S.E. Sartorius, R.C. Donehower, and D.R. Cornblath Peripheral neuropathy from taxol and cisplatin combination chemotherapy: clinical and electrophysiological studies Ann. Neurol. 35 1994 304 311
7. S.L. Mahajan, Y. Ikeda, T.J. Myers, and M.G. Baldini Acute acoustic nerve palsy associated with vincristine therapy Cancer 47 1981 2404 2406
8. G. Lugassy, and A. Shapira Sensorineural hearing loss associated with vincristine treatment Blut 61 1990 320 321
9. M.U. Akyol, S. Sarac, G. Akyol, A. Atac, A. Poyraz, E. Belgin, and E. Turan Investigation of the ototoxic effects of interferon alpha2A on the mouse cochlea Otolaryngol. Head Neck. Surg. 124 2001 107 110
10. D.G.I. Kingston Recent advances in the chemistry of taxol J. Nat. Prod. 63 2000 726 734
11. W.P. McGuire, E.K. Rowinsky, N.B. Rosenshein, F.C. Grumbine, D.S. Ettinger, D.K. Armstrong, and R.C. Donehower Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasm Ann. Intern. Med. 111 1989 273 279
12. ®) Semin. Oncol. 20 Suppl. 3 1993 16 25
13. E.K. Rowinsky, M.R. Gilbert, W.P. McGuire, D.A. Noe, L.B. Grochow, A.A. Forastiere, D.S. Ettinger, B.G. Lubejko, B. Clark, S.E. Sartorius, D.R. Cornblath, C.B. Hendricks, and R.C. Donehower Sequences of taxol and cisplatin: a phase and pharmalogic study J. Clin. Oncol. 9 1991 1692 1703
14. E.K. Rowinsky, N. Onetto, R.M. Canetta, and S.G. Arbuck Taxol: the first of the taxanes, an important new class of antitumor agents Semin. Oncol. 19 1992 646 662
15. H. Gogas, F. Shapiro, C. Aghajanian, D. Fennelly, L. Almadrones, W.J. Hoskins, and D.R. Spriggs The impact of diabetes mellitus on the toxicity of therapy for advanced ovarian cancer Gynecol. Oncol. 61 1996 22 26
16. S.M. Jerian, G.A. Sarosy, C.J. Link, H.J. Fingert, E. Reed, and E.C. Kohn Incapacitating autonomic neuropathy precipitated by taxol Gynecol. Oncol. 51 1993 277 280
17. A. Serafy, and M. Hashash The effect of vincristine on the neurological elements of the rabbit cochlea J. Laryngol. Otol. 95 1981 49 53
18. A. Serafy, M. Hashash, and F. State The effect of vinblastine sulphate on the neurological elements of the rabbit cochlea J. Laryngol. Otol. 96 1982 975 978
19. G. Cavaletti, G. Bogliun, V. Crespi, L. Marzorati, A. Zincone, M. Marzola, S. Rota, A. Galli, P. Tredici, and G. Tredici Neurotoxicity and ototoxicity of cisplatin plus paclitaxel in comparison to cisplatin plus cyclophosphamide in patients with epithelial ovarian cancer J. Clin. Oncol. 15 1997 199 206
20. H. Wandt, J. Birkman, T. Denzel, G. Schafer, G. Schwab, D. Pilz, H. Egger, and A. Both Sequential cycles of high-dose chemotherapy with dose escalation of carboplatin with or without paclitaxel supported by G-CSF mobilized peripheral blood progenitor cells: a phase I/II study in advanced ovarian cancer Bone Marrow Transplant. 23 1999 763 770
21. C. Tibaldi, C. Pazzagli, S. Berrettini, and A. DeVito A case of ototoxicity in a patient with metastatic carcinoma of the breast treated with paclitaxel and vinorelbine Eur. J. Cancer 34 1998 1133 1134
22. T.T.K. Jung, C.K. Rhee, C.S. Lee, Y.S. Park, and D.C. Choi Ototoxicity of salicylate, non-steroidal anti-inflammatory drugs, and quinine Otol. Clin. North Am. 26 1993 791 810